ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Inventories
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Inventories of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2016-06-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2015-12-31 was -$87.54K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2015 was -$9.28K, a 200.00% decline from fiscal 2014.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2014 was $9.28K, a 93.81% decline from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2013 was $149.95K, a 401.76% increase from fiscal 2012.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2012 was $29.88K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed | Increase (Decrease) in Inventories 41 month | Increase (Decrease) in Inventories 44 month | Increase (Decrease) in Inventories 47 month | Increase (Decrease) in Inventories 50 month | Increase (Decrease) in Inventories 53 month | Increase (Decrease) in Inventories 56 month | Increase (Decrease) in Inventories 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | -$87.54K derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | -$87.54K derived: sum of 3 quarters · filed 2017-03-21 | -$52.52K derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | -$87.54K derived: sum of 2 quarters · filed 2017-03-21 | -$52.52K derived: sum of 3 quarters · filed 2017-03-21 | -$91.67K derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2015-12-31 | -$87.54K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -$52.52K derived: sum of 2 quarters · filed 2017-03-21 | -$91.67K derived: sum of 3 quarters · filed 2017-03-21 | -$9.28K 10-K/A · filed 2017-03-21 | |||||||||||
| 2015-09-30 | $35.02K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$4.12K derived: sum of 2 quarters · filed 2017-03-21 | $78.27K 10-Q/A · filed 2017-03-21 | $131.07K 10-Q · filed 2015-11-12 | $41.67K derived: sum of 4 quarters · filed 2017-03-21 | ||||||||||
| 2015-06-30 | -$39.14K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | $43.24K 10-Q/A · filed 2017-03-21 | $61.55K 10-Q · filed 2015-08-06 | $6.65K derived: sum of 3 quarters · filed 2017-03-21 | $50.61K derived: sum of 4 quarters · filed 2017-03-21 | ||||||||||
| 2015-03-31 | $82.39K 10-Q/A · filed 2017-03-21 | $54.84K 10-Q · filed 2015-05-13 | $45.80K derived: sum of 2 quarters · filed 2017-03-21 | $89.75K derived: sum of 3 quarters · filed 2017-03-21 | $91.67K derived: sum of 4 quarters · filed 2017-03-21 | ||||||||||
| 2014-12-31 | -$36.59K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $7.37K derived: sum of 2 quarters · filed 2016-03-30 | $9.28K derived: sum of 3 quarters · filed 2016-03-30 | $9.28K 10-K · filed 2016-03-30 | $39.79K 10-K · filed 2015-03-30 | ||||||||||
| 2014-09-30 | $43.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $45.87K derived: sum of 2 quarters · filed 2015-11-12 | $45.87K 10-Q · filed 2015-11-12 | $195.81K derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||
| 2014-06-30 | $1.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.91K 10-Q · filed 2015-08-06 | $151.86K derived: sum of 3 quarters · filed 2015-08-06 | $131.53K derived: sum of 4 quarters · filed 2015-08-06 | |||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | $149.95K derived: sum of 2 quarters · filed 2015-05-13 | $129.62K derived: sum of 3 quarters · filed 2015-05-13 | $149.95K derived: sum of 4 quarters · filed 2015-05-13 | $271.86K 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | $149.95K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $129.62K derived: sum of 2 quarters · filed 2015-03-30 | $149.95K derived: sum of 3 quarters · filed 2015-03-30 | $149.95K 10-K · filed 2015-03-30 | $271.86K 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | -$20.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 4 quarters · filed 2014-11-12 | $121.91K 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | $20.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $20.32K 10-Q · filed 2014-08-12 | $20.32K derived: sum of 3 quarters · filed 2014-08-12 | $26.40K derived: sum of 4 quarters · filed 2014-08-12 | $142.23K 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $6.08K derived: sum of 3 quarters · filed 2014-03-27 | $53.69K derived: sum of 4 quarters · filed 2014-03-27 | -$121.91K 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $6.08K derived: sum of 2 quarters · filed 2014-03-27 | $53.69K derived: sum of 3 quarters · filed 2014-03-27 | $29.88K 10-K · filed 2014-03-27 | -$29.88K 10-K · filed 2013-03-28 | -$121.91K 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | $6.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $53.69K derived: sum of 2 quarters · filed 2013-11-12 | $29.88K 10-Q · filed 2013-11-12 | -$29.88K 10-Q/A · filed 2013-01-22 | -$62.14K derived: sum of 4 quarters · filed 2013-11-12 | -$121.91K 10-Q/A · filed 2013-01-22 | |||||||||
| 2012-06-30 | $47.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $23.81K 10-Q · filed 2013-08-14 | -$68.22K derived: sum of 3 quarters · filed 2013-08-14 | ||||||||||||
| 2012-03-31 | -$23.81K 10-Q · filed 2013-05-15 | -$115.83K derived: sum of 2 quarters · filed 2013-05-15 | |||||||||||||
| 2011-12-31 | -$92.03K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | -$92.03K 10-K · filed 2013-03-28 | |||||||||||||
| 2011-09-30 | $0.00 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |